Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.

Item
http://www.wikidata.org/entity/Q35112521
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectivenessThe goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence.What is the cost of blindness?Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants.Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration.Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case.Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.The estimated prevalence and incidence of late stage age related macular degeneration in the UKBurden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.Cost-effectiveness of ranibizumab for neovascular age-related macular degenerationCost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis).
P2860

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.

Item
http://www.wikidata.org/entity/Q35112521
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical effectiveness and cos ...... eview and economic evaluation.
@ast
Clinical effectiveness and cos ...... eview and economic evaluation.
@en
type
label
Clinical effectiveness and cos ...... eview and economic evaluation.
@ast
Clinical effectiveness and cos ...... eview and economic evaluation.
@en
prefLabel
Clinical effectiveness and cos ...... eview and economic evaluation.
@ast
Clinical effectiveness and cos ...... eview and economic evaluation.
@en
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
Clinical effectiveness and cos ...... review and economic evaluation
@en
P2093
P304
P31
P433
P478
P577
P698